SCHEMBL5046954

SCHEMBL5046954

C=CCNC(=O)Oc1cc(-c2csc(-c3ccc(OC)cc3)n2)n(CC2CCCCC2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 2/20 0.43
CDC25B P30305 2/20 0.43
CDC25C P30307 2/20 0.43
DUSP3 P51452 2/20 0.43
KDM4E B2RXH2 5/20 0.38
MAPT P10636 4/20 0.38
HPGD P15428 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 2/20 0.38
LMNA P02545 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KLKB1 P03952 1/20 0.37
ALDH1A1 P00352 2/20 0.37
OXTR P30559 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5039914 0.91 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5048642 0.89 CDC25A (0.44) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5048696 0.88 CDC25A (0.43) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5039872 0.88 KLKB1 (0.46) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5043910 0.88 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5140692 0.88 FAAH (0.46) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5044042 0.87 CDC25A (0.42) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5047022 0.87 CDC25A (0.46) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL5039564 0.87 FAAH (0.46) CDC25ACDC25BCDC25CDUSP3MAPT
SCHEMBL5043836 0.86 CDC25A (0.46) CDC25ACDC25BCDC25CDUSP3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP claimed